Envoy Medical, Inc. (COCH)

Market Cap	99.18M
Revenue (ttm)	316,000
Net Income (ttm)	-29.91M
Shares Out	19.60M
EPS (ttm)	-2.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	99,325
Open	5.01
Previous Close	4.98
Day's Range	4.74 - 5.23
52-Week Range	0.75 - 11.72
Beta	1.24
Analysts	Strong Buy
Price Target	6.00 (+18.58%)
Earnings Date	May 16, 2024

About COCH

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 34
• Stock Exchange: NASDAQ
• Ticker Symbol: COCH

Financial Performance

In 2023, Envoy Medical's revenue was $316,000, an increase of 33.33% compared to the previous year's $237,000. Losses were -$29.91 million, 87.8% more than in 2022.

Analyst Forecast

According to 2 analysts, the average rating for COCH stock is "Strong Buy." The 12-month stock price forecast is $6.0, which is an increase of 18.58% from the latest price.

Price Target

$6.0

(18.58% upside)

Analyst Consensus: Strong Buy